GC Cell Corporation develops cell therapy products and provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. The company has a strategic agreement with Lukas Biomedical Co., Ltd. to develop cell therapy. Formerly known as Green Cross Lab Cell Corporation, it changed its name to GC Cell Corporation in November 2021. Founded in 2011, it is based in Yongin-si, South Korea.